mRNA Synthesis and Manufacturing Market Size & Trends Report Segmented by Product (Drug Substance, Drug Product), Service Type (Synthesis, Purification, Manufacturing & Scale-up), Application (Vaccines, Therapeutics), End-user & Regional Forecast to 2030
The global mRNA synthesis and manufacturing market is expected to grow at a CAGR of ~6% during the forecast period. Growing demand for mRNA-based vaccines and therapeutics, increasing cases of infectious and chronic diseases, rapid advancements in lipid nanoparticle (LNP) delivery systems, the emergence of AI-driven platforms for mRNA design and synthesis, and the expansion of contract development and manufacturing organizations (CDMOs) are some of the key factors driving the market growth. However, stability and storage issues associated with mRNA products remain a major constraint for the growth of the mRNA synthesis and manufacturing market. To learn more about the research report, download a sample report.
Overview
The mRNA synthesis and manufacturing market represents a vital part of the biopharmaceutical industry, focused on the production of messenger RNA molecules used in vaccines and therapeutics. It involves several stages, including plasmid preparation, in vitro transcription (IVT), mRNA purification, and formulation, often utilizing lipid nanoparticles (LNPs) for effective delivery. The market includes key components such as enzymes, reagents, templates, specialized delivery systems, mRNA synthesis tools, production platforms, raw materials, analytical instruments, and fill-finish technologies that collectively enable the efficient development and large-scale manufacturing of high-quality mRNA products.

To learn more about this report, download the PDF brochure
Rising demand for mRNA-based vaccines and therapeutics drives market expansion
The global success of mRNA-based COVID-19 vaccines has generated significant interest in mRNA technology for a broad range of applications. According to an article published by the WHO in October 2024, more than 13 billion COVID-19 vaccine doses have been administered globally. The pandemic highlighted the speed, scalability, and effectiveness of mRNA platforms in responding to urgent healthcare challenges. Pharmaceutical and biotech companies are increasingly investing in mRNA-based therapeutics for infectious diseases, cancer, and rare genetic disorders. This growing demand is driving the need for high-quality raw materials, advanced synthesis platforms, and flexible, large-scale production capabilities. Additionally, the expansion of clinical trials and regulatory approvals for mRNA therapies is accelerating market growth.
Growth in personalized cancer immunotherapy drives innovation in mRNA manufacturing
The rising demand for cancer immunotherapy and personalized mRNA-based oncology vaccines presents a significant opportunity for the mRNA synthesis and manufacturing market. Unlike conventional treatments, mRNA-based cancer vaccines are tailored to target tumour-specific antigens, enhancing precision and reducing off-target effects. The personalized nature of these therapies requires rapid, flexible, and high-quality mRNA synthesis capabilities, driving demand for advanced manufacturing platforms, automation, and robust quality control systems.
Recent developments in the mRNA synthesis and manufacturing marketÂ
Recent industry developments highlight the rapid progress in mRNA synthesis and manufacturing, with advances spanning clinical trials, next-generation facilities, and innovative platforms. Companies are expanding capabilities and forging collaborations to accelerate personalized therapies, cancer vaccines, and novel delivery approaches. For instance,
- In April 2025, CureVac received the US FDA Investigational New Drug (IND) application to initiate a phase 1 clinical trial for novel mRNA-based precision immunotherapy in squamous non-small cell lung cancer
- In November 2024, SyVento Biotech, with Cytiva’s support, launched Poland’s first mRNA FlexFactory, an advanced 7,000 m² facility, designed to accelerate high-quality mRNA therapy production from lab to commercial scale
- In May 2024, GenScript launched a self-amplifying RNA synthesis service for advanced therapeutic applications, boosting potency and efficiency for vaccine, immunotherapy, and gene therapy development

To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global mRNA synthesis and manufacturing market is marked by the presence of established and emerging market players such as Lonza Group AG; Wuxi Biologics (Cayman) Inc.; Merck KGaA; Thermo Fisher Scientific Inc.; GenScript Biotech Corporation; Sartorius AG; Takara Bio Inc.; Danaher Corporation; Promega Corporation; New England Biolabs, Inc.; and Telesis Bio Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~6% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Service Type, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Lonza Group AG; Wuxi Biologics (Cayman) Inc.; Merck KGaA, Darmstadt, Germany; Thermo Fisher Scientific Inc.; GenScript Biotech Corporation; Sartorius AG; Takara Bio Inc.; Danaher Corporation; Promega Corporation; New England Biolabs, Inc.; and Telesis Bio Inc.; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Â
Global mRNA Synthesis and Manufacturing Market Segmentation
This report by Medi-Tech Insights provides the size of the global mRNA synthesis and manufacturing market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, service type, application, and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Drug Substance (APIs)
- Drug Product (FDFs)
- Others
Market Size & Forecast (2023-2030), By Service Type, USD Million
- Synthesis
- Purification
- Manufacturing & Scale-up
- Others
Market Size & Forecast (2023-2030), By Application, USD Million
- mRNA-based Vaccines
- mRNA-based Therapeutics
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Biopharma Companies
- Academic & Research Institutes
- Contract Development and Manufacturing Organizations (CDMOs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the mRNA synthesis and manufacturing market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the mRNA synthesis and manufacturing market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Related Reports
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Laboratory Robotics Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Growing demand for high-throughput screening (HTS)
- Advancements in robotics and automation technologies
- Increasing R&D investments in life sciences
- Rising focus on precision and reproducibility
- Labor shortages and rising costs of skilled workforce
- Growing need for personalized medicine
- Restraints​
- High initial investment and maintenance costs
- Integration complexity
- Data security and compliance concerns
- Reluctance to change and workforce resistance
- Opportunities​
- Integration of AI, ML, and advanced analytics
- Adoption in clinical diagnostics and healthcare
- Emerging applications in synthetic biology and microbiome research
- Expansion into academic and CROs
- Key Market Trends​
- Smart labs & digital twins
- Rise of modular and affordable robotics
- Unmet Market Needs​
- Industry Speaks​
- Drivers
- Market Dynamics
- Global Laboratory Robotics Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction​
- Robotic Arms
- Automated Liquid Handling Systems
- Automated Plate Handlers
- Lab Automation Workstations
- Microplate Readers and Washers
- Automated Storage and Retrieval System
- Others
- Global Laboratory Robotics Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction​
- Drug Discovery and Development
- Clinical Diagnosis
- Microbiology
- Genomics
- Proteomics
- Analytical Chemistry
- Others
- Global Laboratory Robotics Market Size & Forecast (2023-2030), By End User, USD Million​
- Introduction
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Clinical & Diagnostic Laboratories
- Others
- Global Laboratory Robotics Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Laboratory Robotics Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Canada​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- US​
- Europe Laboratory Robotics Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Germany ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- France ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Italy ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Spain ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Rest of Europe ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- UK ​
- Asia Pacific (APAC) Laboratory Robotics Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Japan ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- India ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- China ​
- Latin America (LATAM) Laboratory Robotics Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Middle East & Africa (MEA) Laboratory Robotics Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific Inc.
- Peak Analysis and Automation
- Tecan Trading AG
- Revvity
- Hudson Lab Automation
- DH Life Sciences, LLC
- Siemens Healthineers AG
- Agilent Technologies, Inc.
- Anton Paar GmbH
- AB Controls
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)

Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Biopharma Companies, Academic & Research Institutes; CDMOs, and Others
Breakdown of Primary InterviewsÂ

Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel


